BioNTech's COVID-19 vaccine revenue forecasts lower than expected

Submitted by admin on March 27, 2023 - 10:19am

Source:

Biopharma Reporter

News Tags:

Headline:

snippet:

BioNTech expects revenue from its COVID-19 vaccines to hit €5bn (US$5.3bn) in 2023, which would be lower than market expectations.

Search form